Vicarious Surgical to Report First Quarter 2023 Financial Results on May 8, 2023

Rhea-AI Summary

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) announced it will release its financial results for the first quarter ended March 31, 2023, on May 8, 2023, after market close. The company will host a conference call at 4:30 p.m. Eastern Time to discuss these results. Vicarious Surgical is focused on advanced surgical robotics with the aim of enhancing surgical efficiency, improving patient outcomes, and reducing healthcare costs. Backed by prominent investors, including Bill Gates and Khosla Ventures, the company is known for its innovative approach that transports surgeons inside patients for minimally invasive surgeries. Stakeholders can access further information via the company's investor website.

Positive

• Announcement of Q1 2023 financial results on May 8, 2023, potentially indicating ongoing operational transparency.
• The company's unique approach to surgical robotics aims to significantly improve surgical efficiency and reduce healthcare costs.

Negative

• None.

WALTHAM, Mass.--(BUSINESS WIRE)-- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the first quarter ended March 31, 2023, after the market closes on Monday, May 8, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by dialing +1 (404) 975 4839 for domestic callers or + 1 (929) 526 1599 for international callers, using access code: 985501. A live and archived webcast of the event will be available at https://investor.vicarioussurgical.com.

About Vicarious Surgical

Founded in 2014, Vicarious Surgical is a next-generation surgical robotics company, developing a unique disruptive technology with the multiple goals of substantially increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company’s novel surgical approach uses proprietary human-like surgical robots to transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Massachusetts. Learn more at www.vicarioussurgical.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230424005086/en/

Investor Contact

Kaitlyn Brosco

Vicarious Surgical

Kbrosco@vicarioussurgical.com

Marissa Bych

Gilmartin Group

Marissa@gilmartinir.com

Media Inquiries

Abby Mayo for Matter Health

media@vicarioussurgical.com

Source: Vicarious Surgical Inc.

FAQ

When will Vicarious Surgical report its Q1 2023 financial results?

Vicarious Surgical will report its Q1 2023 financial results on May 8, 2023, after market close.

What time is the Vicarious Surgical conference call regarding Q1 2023 results?

The conference call will take place at 4:30 p.m. Eastern Time on May 8, 2023.

How can I access Vicarious Surgical's Q1 2023 financial results?

Investors can listen to the conference call by dialing +1 (404) 975 4839 for domestic or +1 (929) 526 1599 for international callers, using access code 985501.

What is the business focus of Vicarious Surgical?

Vicarious Surgical is focused on developing advanced surgical robotics to improve surgical efficiency, patient outcomes, and reduce healthcare costs.